Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors (vol 13, 1247291, 2023)
FRONTIERS IN ONCOLOGY（2024）
关键词
endometrial cancer,molecular classification,immune checkpoint inhibitors,dostarlimab,pembrolizumab plus lenvatinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要